Cosmetic Compliance
Intelligence & Solutions
Cosmetic
ChemLinkedMarketChemicalFoodCosmeticPharmaceuticalJapanAgrochemicalSustainability
Home / Database / Regulatory Database
Technical Guidelines for Supervision of Production and Distribution Facilities of Traditional Drug, Quasi-Drugs, Health Supplements, and Cosmetics during COVID-19
Local Title:
NOMOR HK.02.02.4.41.06.21.20 TAHUN 2021 TENTANG PETUNJUK TEKNIS PELAKSANAAN PENGAWASAN SARANA PRODUKSI DAN DISTRIBUSI OBAT TRADISIONAL, OBAT KUASI, SUPLEMEN KESEHATAN, DAN KOSMETIKA SELAMA MASA PANDEMI CORONA VIRUS DISEASE 2019 (COVID-19)
Country/Region:
Indonesia
Competent Authority:
Badan Pengawas Obat dan Makanan
Type:
Notice
Status:
In force
Release Date:
2021-06-22
Implementation Date:
2021-06-22
Document
Language Source Title Access
ID
 Official Technical Guidelines for Supervision of Production and Distribution Facilities of Traditional Drug, Quasi-Drugs, Health Supplements, and Cosmetics during COVID-19
Download
On-demand Translation Service
Technical Guidelines for Supervision of Production and Distribution Facilities of Traditional Drug, Quasi-Drugs, Health Supplements, and Cosmetics during COVID-19
Request
request
Summary

Indonesian BPOM considers that it is necessary to make adjustments to the implementation of the supervision of the production and distribution facilities of traditional medicines, quasi-drugs, health supplements, and cosmetics because of the impact of COVID-19.

The scope of this Technical Guidelines contains the implementation of supervision of production and distribution facilities of traditional medicines, quasi-drugs, health supplements, and cosmetics during the COVID-19 pandemic as a reference for BPOM officers.

Noteworthy Information